1813P Phase I/II trial of oral EPI-7386 in combination with enzalutamide (enz) compared to enz alone in metastatic castration-resistant prostate cancer (mCRPC) subjects: Current phase I (PI) results
Saved in:
Published in | Annals of oncology Vol. 34; pp. S982 - S983 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Ltd
01.10.2023
|
Online Access | Get full text |
ISSN | 0923-7534 1569-8041 |
DOI | 10.1016/j.annonc.2023.09.2761 |
Cover
Loading…
Author | Younginger, B. Kyriakopoulos, C. Le Moigne, R. Chatta, G. Markowski, M.C. Iannotti, N. Cesano, A. Saad, F. Pili, R. Laccetti, A.L. Vuky, J. Hotte, S.J. Zhang, J. Villaluna, K. |
---|---|
Author_xml | – sequence: 1 givenname: A.L. surname: Laccetti fullname: Laccetti, A.L. organization: Department of Medicine, Division of Solid Tumor Oncology, MSKCC - Memorial Sloan Kettering Cancer Center, New York, NY, USA – sequence: 2 givenname: G. surname: Chatta fullname: Chatta, G. organization: Oncology Department, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA – sequence: 3 givenname: C. surname: Kyriakopoulos fullname: Kyriakopoulos, C. organization: Hematology/Oncology, UW Carbone Cancer Center, Madison, WI, USA – sequence: 4 givenname: N. surname: Iannotti fullname: Iannotti, N. organization: Oncology Department, Hematology Oncology Associates of the Treasure Coast, Fort Pierce, FL, USA – sequence: 5 givenname: S.J. surname: Hotte fullname: Hotte, S.J. organization: Oncology Department, JCC - Juravinski Cancer Centre - Hamilton Health Sciences, Hamilton, Ontario, ON, Canada – sequence: 6 givenname: M.C. surname: Markowski fullname: Markowski, M.C. organization: Oncology Department, Johns Hopkins Sidney Kimmel Cancer Center, Baltimore, MD, USA – sequence: 7 givenname: R. surname: Pili fullname: Pili, R. organization: Medicine Department, University of Buffalo - Clinical and Translational Research Center, Buffalo, NY, USA – sequence: 8 givenname: J. surname: Vuky fullname: Vuky, J. organization: Division of Hematology & Medical Oncology, OHSU Knight Cancer Institute - Center for Health and Healing Building 2, Portland, OR, USA – sequence: 9 givenname: J. surname: Zhang fullname: Zhang, J. organization: Genito Urinary, H. Lee Moffitt Cancer Center & Research Institute - Magnolia Campus, Tampa, FL, USA – sequence: 10 givenname: F. surname: Saad fullname: Saad, F. organization: Urology Department, Hospital St. Luc du CHUM, Montreal, QC, Canada – sequence: 11 givenname: K. surname: Villaluna fullname: Villaluna, K. organization: Clinical Dpt, ESSA Pharmaceuticals Corp., South San Francisco, CA, USA – sequence: 12 givenname: B. surname: Younginger fullname: Younginger, B. organization: Clinical Dpt, ESSA Pharmaceuticals Corp., South San Francisco, CA, USA – sequence: 13 givenname: R. surname: Le Moigne fullname: Le Moigne, R. organization: Clinical Dpt, ESSA Pharmaceuticals Corp., South San Francisco, CA, USA – sequence: 14 givenname: A. surname: Cesano fullname: Cesano, A. organization: Clinical Dpt, ESSA Pharmaceuticals Corp., South San Francisco, CA, USA |
BookMark | eNqFUU1v1DAQtVCR2BZ-AtIcdw9J_bF2YjggFBWIVIkIwdlynInqVTZZ2V4q-IH8LpwuJy49jT0z7-nNe9fkal5mJOQtoyWjTN0eSjvnlis55aKkuuSVYi_Ihkmli5ru2RXZUM1FUUmxf0WuYzxQSpXmekP-sJqJDroHGxHa27aFFLydYBlhCbnedW1RiVqBn8Etx97PNvllhkefHgDn33Y6J3v0A8I2_3brzskGHCAt6xjslLWu4CMmG1MGO3D5EZ5oioDR5-6c4BSWdYx5OjsMsD0237pmB_HcH9Cl-A6acwi4bl60wrZrd5AJzlOKr8nL0U4R3_yrN-THp7vvzZfi_uvntvl4XzhOGSu4HrUYBos1l1KMvaCO1lIOqud2T1E6VjtKUQmpOdv3TFth1agGSXvlhqoSN0ReeF2WGwOO5hT80YZfhlGzhmEO5hKGWcMwVJs1jIx7_x_O-fRkQXbCT8-iP1zQmE_76TGY6DxmmwYfsjdmWPwzDH8B-56rhQ |
CitedBy_id | crossref_primary_10_1080_14737140_2024_2379913 |
ContentType | Journal Article |
Copyright | 2023 European Society for Medical Oncology |
Copyright_xml | – notice: 2023 European Society for Medical Oncology |
DBID | AAYXX CITATION |
DOI | 10.1016/j.annonc.2023.09.2761 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1569-8041 |
EndPage | S983 |
ExternalDocumentID | 10_1016_j_annonc_2023_09_2761 S0923753423035986 |
GroupedDBID | --- -E4 .2P .86 .I3 .XZ .ZR 08P 0R~ 0U7 1TH 23M 2WC 4.4 482 48X 53G 5GY 5VS 5WA 6.Y 6J9 70D AABJS AABMN AAEDW AAESY AAIAV AAIYJ AAJKP AAJQQ AAKAS AAKUH AAMVS AAOGV AAPNW AAUQX AAXUO ABEUO ABIXL ABJNI ABKDP ABLJU ABNKS ABOCM ABQLI ABQTQ ABSAR ABSMQ ABVKL ABZBJ ACGFO ACGFS ACIMA ACMRT ACPQN ACPRK ACUFI ACUTO ADBBV ADEIU ADEYI ADHKW ADHZD ADJQC ADOCK ADORX ADQLU ADRIX ADRTK ADYVW ADZCM ADZXQ AEGPL AEGXH AEJOX AEKPW AEKSI AEMDU AENEX AENZO AEPUE AEWNT AFIYH AFOFC AFXEN AGINJ AGKEF AGKRT AGSYK AHMBA AHXPO AIAGR AIJHB AIKOY AITUG ALMA_UNASSIGNED_HOLDINGS ALUQC AMRAJ APIBT APWMN AQKUS ASMCH ASPBG ATTQO AVWKF AWCFO AXUDD AZFZN AZQFJ BAWUL BAYMD BEYMZ BGNMA BGYMP BHONS BTRTY BVRKM BZKNY C1A CAG CASEJ CDBKE CKLRP COF CS3 CZ4 DAKXR DIK DILTD DL5 DPORF DPPUQ D~K E3Z EBS EE~ EJD EX3 F9B FDB FEDTE GJXCC GX1 H5~ HAR HVGLF HW0 HZ~ I09 IH2 IHE IOX J21 KAQDR KC5 KDC KOM KOP KQ8 KSI KSN LAK M-Z M41 M49 M4Y MBLQV MHKGH N9A NCXOZ NGC NOYVH NTWIH NU- NU0 NVLIB O9- OAWHX ODMLO OJQWA OK1 OVD P2P P6G PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RNI ROL ROX ROZ RPX RW1 RXO RZC RZE RZF RZO SDH TCURE TEORI TJX TMA TR2 U2A W8F WOQ WOW X7H YAYTL YFH YKOAZ ZKX ZXP ~91 AAGQS AALRI AAYWO AAYXX ABNGD ACUKT ACVFH ADCNI ADVLN AEHUL AEUPX AFETI AFJKZ AFPUW AFSHK AGCQF AGQPQ AIGII AKBMS AKRWK AKYEP APXCP CITATION H13 |
ID | FETCH-LOGICAL-c2011-29f93ddae82553fb30c0855d6b2a40e5c18c00e6359214b19a3a6f6d50b6cd773 |
ISSN | 0923-7534 |
IngestDate | Tue Jul 01 04:13:48 EDT 2025 Thu Apr 24 23:08:53 EDT 2025 Fri Feb 23 02:35:47 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c2011-29f93ddae82553fb30c0855d6b2a40e5c18c00e6359214b19a3a6f6d50b6cd773 |
OpenAccessLink | http://www.annalsofoncology.org/article/S0923753423035986/pdf |
ParticipantIDs | crossref_primary_10_1016_j_annonc_2023_09_2761 crossref_citationtrail_10_1016_j_annonc_2023_09_2761 elsevier_sciencedirect_doi_10_1016_j_annonc_2023_09_2761 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | October 2023 2023-10-00 |
PublicationDateYYYYMMDD | 2023-10-01 |
PublicationDate_xml | – month: 10 year: 2023 text: October 2023 |
PublicationDecade | 2020 |
PublicationTitle | Annals of oncology |
PublicationYear | 2023 |
Publisher | Elsevier Ltd |
Publisher_xml | – name: Elsevier Ltd |
SSID | ssj0006929 |
Score | 2.42728 |
SourceID | crossref elsevier |
SourceType | Enrichment Source Index Database Publisher |
StartPage | S982 |
Title | 1813P Phase I/II trial of oral EPI-7386 in combination with enzalutamide (enz) compared to enz alone in metastatic castration-resistant prostate cancer (mCRPC) subjects: Current phase I (PI) results |
URI | https://dx.doi.org/10.1016/j.annonc.2023.09.2761 |
Volume | 34 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswECXSBCh6Kbqi6YY59ODAkKJQm9WbYaSNmgVGFjQ3gaQoxKktGa18aD6w39NP6IxI2WprdMlFsCiSGmiexZnRzCNjb6IwEQHnsYPWqkYHxZOOHBSB48tQo9-TKJlTcfLxSXRwEXy4DC83Nr53spYWtXTVzdq6kttoFdtQr1Ql-x-aXU6KDfgb9YtH1DAe_0nHuG764_74CleiforTpGnf7MKBFmBTeb8_Th3ab7Nvss3RCzb6bqKvurwRKJ2YTfLG0MRzihEss9LRKsWmvphWhllkpmtB9UcT1Veipdt10F0nE7SsKdWrKU-iRDJFDBV8MBudjkc06ZeFpIBPk3_XUkLNjdzUb5xSJ5xqMTXMUu5v_M5VqX76AnAklNK1SUYYukduJ0-hNhbx-2Xb4Vd8Kp-qebWYmqzC0fJSKsqystOcuN0YCF9l09nAXFucs8qEaiKc2BG9MROv0Pb9HiUOUS51FwDbw7zBzxKzGZK1BvDUX7vSmKDHtUtSlsSFyX0izOWx4Zb_hcT7jIQhWdDjI87E6A7b4ujY8E22NTw8_Xi4tB6ihBt-SCv8qupsd-3N1ttTHRvp_AG7b50bGBqkPmQbunzE7h7b9I3H7FsDWGgAC-lumkIDV6gKILhCC1eYlNCBKxBcoQtX6OHZDrRQhbqiy9BAlQavoArroAotVMFAFXoNUHeghelbsCCFuZEVeuN0ByxAn7CLd_vnowPHbiTiqOYTAE-KxM9zoQfoQPuF9D1F6Zl5JLkIPB2qvYHyPI22d8L3ArmXCF9ERZSHnoxUHsf-U7aJD14_YyAkKkbHSkU6DOJIirgIioHmSRjnoYyLbRa06siUZdmnzV6mWZtOeZ0ZLWakxcxLMtLiNnOXw-aGZuZvAwatrjNrKxsbOEOA_nno89sPfcHurf5-L9lm_XmhX6FRXsvXFsc_ADWZ4PY |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=1813P+Phase+I%2FII+trial+of+oral+EPI-7386+in+combination+with+enzalutamide+%28enz%29+compared+to+enz+alone+in+metastatic+castration-resistant+prostate+cancer+%28mCRPC%29+subjects%3A+Current+phase+I+%28PI%29+results&rft.jtitle=Annals+of+oncology&rft.au=Laccetti%2C+A.L.&rft.au=Chatta%2C+G.&rft.au=Kyriakopoulos%2C+C.&rft.au=Iannotti%2C+N.&rft.date=2023-10-01&rft.pub=Elsevier+Ltd&rft.issn=0923-7534&rft.eissn=1569-8041&rft.volume=34&rft.spage=S982&rft.epage=S983&rft_id=info:doi/10.1016%2Fj.annonc.2023.09.2761&rft.externalDocID=S0923753423035986 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0923-7534&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0923-7534&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0923-7534&client=summon |